Home / Etomidate / United States
US ATC N01AX07 · updated 2 Nov 2026
Etomidate shortage in United States
Is there an Etomidate shortage in United States?
Yes. As of 2 Nov 2026, 18 Etomidate products are reported short in United States, the first since 5 Oct 2022. No return date has been given. Main reason: not stated.
Also short in Austria, Belgium. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Amidate, Injection, 2 mg/1 mL (NDC 0409-6695-01) | Hospira, Inc., a Pfizer Company | 5 Oct 2022 | not given | Other |
| US | Amidate, Injection, 2 mg/mL (NDC 0409-6695-02) | Hospira, Inc., a Pfizer Company | 5 Oct 2022 | not given | Other |
| US | Etomidate, Injection, 2 mg/1 mL (NDC 0143-9310-10) | Hikma Pharmaceuticals USA, Inc. | 5 Oct 2022 | not given | Not stated |
| US | Etomidate, Injection, 2 mg/1 mL (NDC 0143-9311-10) | Hikma Pharmaceuticals USA, Inc. | 5 Oct 2022 | not given | Not stated |
| US | Etomidate, Injection, 2 mg/1 mL (NDC 0143-9506-10) | Hikma Pharmaceuticals USA, Inc. | 5 Oct 2022 | not given | Not stated |
| US | Etomidate, Injection, 2 mg/1 mL (NDC 0143-9507-10) | Hikma Pharmaceuticals USA, Inc. | 5 Oct 2022 | not given | Not stated |
| US | Etomidate, Injection, 2 mg/1 mL (NDC 67457-902-10) | Mylan Institutional, a Viatris Company | 5 Oct 2022 | not given | Increased demand Demand increase for the drug |
| US | Etomidate, Injection, 2 mg/1 mL (NDC 67457-903-20) | Mylan Institutional, a Viatris Company | 5 Oct 2022 | not given | Not stated |
| US | Etomidate, Injection, 2 mg/1 mL (NDC 72266-146-10) | Gland Pharma Limited | 5 Oct 2022 | not given | Not stated |
| US | Etomidate, Injection, 2 mg/1 mL (NDC 72266-147-10) | Gland Pharma Limited | 5 Oct 2022 | not given | Not stated |
| US | Etomidate, Injection, 2 mg/1 mL (NDC 72572-160-10) | Hikma Pharmaceuticals USA, Inc. | 5 Oct 2022 | not given | Not stated |
| US | Etomidate, Injection, 2 mg/1 mL (NDC 72572-161-10) | Hikma Pharmaceuticals USA, Inc. | 5 Oct 2022 | not given | Not stated |
| US | Etomidate, Injection, 2 mg/mL (NDC 72485-508-10) | Caplin Steriles, Ltd. | 5 Oct 2022 | not given | Not stated |
| US | Etomidate, Injection, 2 mg/mL (NDC 72485-509-10) | Caplin Steriles, Ltd. | 5 Oct 2022 | not given | Not stated |
| US | Etomidate, Injection, 20 mg/10 mL (NDC 55150-221-10) | Eugia US LLC | 5 Oct 2022 | not given | Increased demand Demand increase for the drug |
| US | Etomidate, Injection, 2mg/1 mL (NDC 65219-445-10) | Caplin Steriles, Ltd. | 5 Oct 2022 | not given | Not stated |
| US | Etomidate, Injection, 2mg/mL (NDC 65219-447-20) | Caplin Steriles, Ltd. | 5 Oct 2022 | not given | Not stated |
| US | Etomidate, Injection, 40 mg/20 mL (NDC 55150-222-20) | Eugia US LLC | 5 Oct 2022 | not given | Increased demand Demand increase for the drug |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).